2 results
Approved WMOCompleted
The primary objective is to demonstrate the safety and feasibility of the STENTYS-BDS.
Approved WMOCompleted
To assess and compare efficacy (complete response [CR] rate and overall survival [OS]) between SGI-110 and TC in adults with previously untreated AML who are not considered candidates for intensive remission induction chemotherapy.